Their results highlight the powerful anti-tumor potential of IL-15-based treatments combined with immune modulatory anti-MICA/B and anti-NKG2A (Fig. 3) for cancer treatment for which co-cultured spheroids deeply help to characterize the efficacy and mode of action [139]. Here, KLRC1 is linked to cancer.